Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03220880 · ClinicalTrials.gov registry record
Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 578
- Enrollment target
NCT03220880: Completed study, sponsored by Columbia University.
NCT03220880 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 578 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03220880 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 578 participants
- Enrollment target
Study Summary
Specific Aim 1: To describe the adequacy of sedation associated with different regimens of IN DEX in children undergoing non-painful procedures. This aim will test the working hypothesis that IN DEX regimens are effective for producing sedation adequate for completion of non-painful procedures in children. Specific Aim 2: To describe the temporal characteristics associated with varied regimens of IN DEX in children undergoing non-painful procedures, such as time to onset of adequate sedation; time to procedure start; and time from procedure end to meeting discharge criteria. This aim will test the working hypothesis that IN DEX regimens have temporal characteristics that are favourable for sedating children for non-painful procedures. Specific Aim 3: To describe the adverse events associated with varied regimens of IN DEX in children undergoing non-painful procedures. This aim will test the working hypothesis that IN DEX regimens have a low incidence of adverse events.
Primary Outcome
Pediatric Sedation State Scale
Interventions
- DRUG Intranasal dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 578 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2020-01-31 |
What the finished NCT03220880 record still lists
NCT03220880 is an observational study that tracks outcomes without assigning an intervention. The registered 578 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Intranasal dexmedetomidine is the first listed.
NCT03220880 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03220880 about?
NCT03220880 is a clinical study titled "Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures". Specific Aim 1: To describe the adequacy of sedation associated with different regimens of IN DEX in children undergoing non-painful procedures. This aim will test the working hypothesis that IN DEX regimens are effective for producing sedation adequate for completion of non-painful procedures in ch...
What is the current status of trial NCT03220880?
This trial is currently completed. The enrollment target is 578 participants. The study started on 2018-09-04. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT03220880?
The interventions under investigation include: Intranasal dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT03220880?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07290543 · 578 participants · NA
Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors
- NCT04575935 · 580 participants · Phase 3
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- NCT05143177 · 580 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
- NCT05696353 · 580 participants · Phase 3
Teen Driving Translation Study (NIH)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI